Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02928978
Title Ruxolitinib for Premalignant Breast Disease
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Julie Nangia
Indications

ductal carcinoma in situ

lobular neoplasia

Therapies

Ruxolitinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.